A Rockville cancer clinic is at the forefront of a budding renaissance in psychedelic medicine. Can doctors there unlock the mental-health benefits of the long-banned drugs?
Clinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has announced that global psychedelic therapy and science experts Doctor Bill Richards, Dr Andrea Jungaberle and Professor Matthew Johnson have joined the advisory board of its newly-established subsidiary Clarion Clinics Group.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), a pharmaceutical company developing cannabis-infused drugs and psychedelic-assisted psychotherapy protocols,.